Stocks  /  NASDAQ  /  MapLight Therapeutics Inc.

MapLight Therapeutics Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   MPLT – NASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

MapLight Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following press release that they use animals for drug testing.

“These results are consistent with our compelling pre-clinical evidence for reduction in aggression/irritability in animal models. Given that there is an established regulatory path in this indication using the ABC-I, and given the magnitude of the effect on this measure observed in this study, we look forward to engaging with the FDA to discuss a possible path forward. We are grateful to the participants, families, and investigators whose commitment made this trial possible.” Read the following article

Company Description

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company was formerly known as Alvarado Therapeutics, Inc. and changed its name to MapLight Therapeutics, Inc. in August 2019. MapLight Therapeutics, Inc. was incorporated in 2018 and is based in Redwood City, California.

Company Website: https://www.maplightrx.com

Contact:  investors@maplightrx.com
Scroll to Top